Standfirst: In 2023, the healthcare industry in China was subject to significant legislative advancements and reforms aimed at addressing industry concerns and promoting innovation. Zhou Hanshuo and Wang Xiaoyun of Jingtian & G...
The article reports on the analysis of the trends in the healthcare industry in China as of March 2013 and provides industry forecasts for 2013-2017. It states that healthcare spending will likely exceed U.S.$900 billion annually by 2017. It mentions that population ageing will drive health...
The government's timely policies to improve business environment and efforts to facilitatehigh-quality developmenthave paved the way for the rapid growth of theonline healthcare industryin China. 中国政府及时出台政策改善营商环境,积极促进高质量发展,这些举措为在线医疗产业的快速发展铺平了道路。 Relatedexp...
It is therefore not surprising that multinationals are ramping up their investments in China, tapping into the huge population's unmet needs, the nation's manufacturing and emerging R&D ecosystem, and the government's support for the biomedical industry. Following th...
CHINA, JUNE 2020 – With the prevalence of COVID-19 worldwide, the healthcare industry in China began to see a massive shift from face-to-face meetings to remote consultations over the last few months. To overcome this steep transition, healthcare diagnostics company Sysmex partnered with Micro...
The new reforms introduced by the Government in 2015 target three main areas: infrastructure development, reduction of costs and new investments. The wide ranging scope of these reforms will have a substantial impact on stakeholders and industry players including: international medical device f...
Data by iiMedia Research reveals that the market size of China’s healthcare product industry was 298.9 billion, a year-on-year increase of 10.4% and it is expected to reach 423.7 billion yuan in 2027. Analysts from AskCI Consulting hold that in the short run, the domestic market of healt...
The total investment in research and development in China's medical industry has increased annually by 23 percent on average over the past years since the VBP policy came into force, Ding said. According to a circular issued by the NHSA on Monday, China will promote the procurement of more ...
Other than India, China will be IHH's another key potential market for its rising medical demand from a large, growing middle class, the group mentioned earlier.
Current situation of AI in the healthcare industry in China: How are healthcare AI companies in China developing? There are four pain points in Chinese medical field: insufficient medical resources, a long training period for doctors, high medical costs, and a high doctor misdiagnosis rate. AI...